4 Results for "

hypolipidemic drug

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "hypolipidemic drug" in MCE Product Catalog:

Cat. No.: HY-119964
CAS No.: 55986-43-1
Purity:  ≥99.0%
Target:  

PPAR

Research Areas:  

Cardiovascular Disease

Cetaben is a PPARα-independent peroxisome proliferator. Cetaben is a non-fibrate hypolipidemic agent and potently reduces the concentration of cholesterol and triglycerides .
loading...
    loading...
Cat. No.: HY-B1734
CAS No.: 979-02-2
Synonyms: 16-DPA
16-Dehydropregnenolone acetate (16-DPA), a sterols compound, is an orally active 17α-hydroxylase and 5α-reductase inhibitor. 16-Dehydropregnenolone is also a potent bile acid receptor (BAR)/farnesoid X receptor (FXR) antagonist. 16-Dehydropregnenolone hypolipidemic and anticancer effects. 16-Dehydropregnenolone acetate (16-DPA) is the drug intermediate that can be used for synthesis of Dexamethasone (HY-14648) and related other steroidal pharmacophores .
loading...
    loading...
Cat. No.: HY-19227
CAS No.: 153655-35-7
Target:  

PPAR

Research Areas:  

Cardiovascular Disease

BM 170249 is a peroxisome proliferator, particularly in the perivenous region of the central acini in the liver. BM 170249 significantly reduces serum triglyceride and cholesterol levels in rats. BM 170249 strongly induces the activity of key enzymes in the peroxisome fatty acid β-oxidation system (such as acyl-CoA oxidase AOX, multifunctional enzyme PH, and thiolase PT), but leads to decreased activity of catalase and uricase in peroxisome components. BM 170249 could be used in lipid-lowering studies .
loading...
    loading...
Cat. No.: HY-137390A
CAS No.: 1009811-63-5
(3S,5R)-Fluvastatin (potassium) is a synthetic hypolipidemic drug that inhibits HMG-CoA reductase activity. (3S,5R)-Fluvastatin (potassium) has similar antioxidative effects on copper ion-induced LDL oxidation compared to its 3R,5S enantiomer. (3S,5R)-Fluvastatin (potassium) and its metabolites demonstrate a potential to exhibit anti-atherosclerotic effects through their antioxidative activities. (3S,5R)-Fluvastatin (potassium) is clinically utilized as part of a racemic mixture for reducing plasma cholesterol levels.
loading...
    loading...